{"id":449339,"date":"2021-03-03T07:33:10","date_gmt":"2021-03-03T12:33:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=449339"},"modified":"2021-03-03T07:33:10","modified_gmt":"2021-03-03T12:33:10","slug":"verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/","title":{"rendered":"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WEST CHESTER, Pa., March  03, 2021  (GLOBE NEWSWIRE) &#8212; Verrica Pharmaceuticals Inc. (\u201cVerrica\u201d) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will present a business overview at the H.C. Wainwright Annual Global Life Sciences Conference, taking place March 9-10, 2021.<\/p>\n<p>A pre-recorded presentation will be available for on-demand access beginning at 7:00 a.m. ET on Tuesday, March 9, 2021. Participants may access a webcast of the event through the following link:<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Y4c5zXstFZUpYzWxbT0_DbUcttzLaP7InhxBSl4rmFTKwHvLd1hJ6bnx5aBUUQ4vL4DHbefWZ9mDmQ0Nm-nMvFQ2uMQgReeJwQOdBWQ2OAgZkdycC75fT_LHOtkB_v0bYWRMWhAn1cW0QDO3uUw0AzagNecunoH4OHijTOlkdsf3q1i5EupDfjA_eOeKBTofHuOf8c2yNn9vF3YfPD9gOg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/journey.ct.events\/view\/920684dd-5942-496a-9960-f3619118a62d<\/a>.<\/p>\n<p>The webcast can also be accessed in the Investors\/Presentations &amp; Events section of the Verrica website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sS-sD4GKMAAAdrosIpMdPSjzrspQhYG8bgemsY6yaDpqlDbnrwqCgbpAhUkLXgFpcScF-4V8Y6J4OkZLywkHTQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.verrica.com<\/a>. The webcast replay will be available shortly after conclusion of the event for 30 days.<\/p>\n<p>\n        <strong>About Verrica Pharmaceuticals Inc.<\/strong>\n      <\/p>\n<p>Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica\u2019s late-stage product candidate, VP-102, is in development to treat molluscum, common warts and external genital warts, three of the largest unmet needs in medical dermatology. Verrica is also developing VP-103, its second cantharidin-based product candidate, for the treatment of plantar warts. The Company has also entered a worldwide license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatologic oncology conditions. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sS-sD4GKMAAAdrosIpMdPTXIwFEiLY2OPo7bbRHOcdyMExJ29eOZB110StVF5m9ZzJo-9xsnFbdvTtvMdEp1uw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.verrica.com<\/a>.<\/p>\n<p>\n        <strong>FOR MORE INFORMATION, PLEASE CONTACT:<\/strong>\n      <\/p>\n<p>Investors:<\/p>\n<p>\n        <strong>A. Brian Davis<\/strong><br \/>\n        <br \/>Chief Financial Officer<br \/>484.453.3300 ext. 103<br \/>info@verrica.com<\/p>\n<p>\n        <strong>William Windham<\/strong><br \/>\n        <br \/>Solebury Trout<br \/>646.378.2946<br \/>wwindham@troutgroup.com<\/p>\n<p>Media:<\/p>\n<p>\n        <strong>Zara Lockshin<\/strong><br \/>\n        <br \/>Solebury Trout<br \/>646.378.2960<br \/>zlockshin@troutgroup.com<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/948da764-70ae-4a73-9e33-79035274a8e2\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WEST CHESTER, Pa., March 03, 2021 (GLOBE NEWSWIRE) &#8212; Verrica Pharmaceuticals Inc. (\u201cVerrica\u201d) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will present a business overview at the H.C. Wainwright Annual Global Life Sciences Conference, taking place March 9-10, 2021. A pre-recorded presentation will be available for on-demand access beginning at 7:00 a.m. ET on Tuesday, March 9, 2021. Participants may access a webcast of the event through the following link:https:\/\/journey.ct.events\/view\/920684dd-5942-496a-9960-f3619118a62d. The webcast can also be accessed in the Investors\/Presentations &amp; Events section of the Verrica website at www.verrica.com. The webcast replay will be available shortly after conclusion of the event for 30 days. About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-449339","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WEST CHESTER, Pa., March 03, 2021 (GLOBE NEWSWIRE) &#8212; Verrica Pharmaceuticals Inc. (\u201cVerrica\u201d) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will present a business overview at the H.C. Wainwright Annual Global Life Sciences Conference, taking place March 9-10, 2021. A pre-recorded presentation will be available for on-demand access beginning at 7:00 a.m. ET on Tuesday, March 9, 2021. Participants may access a webcast of the event through the following link:https:\/\/journey.ct.events\/view\/920684dd-5942-496a-9960-f3619118a62d. The webcast can also be accessed in the Investors\/Presentations &amp; Events section of the Verrica website at www.verrica.com. The webcast replay will be available shortly after conclusion of the event for 30 days. About &hellip; Continue reading &quot;Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-03T12:33:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference\",\"datePublished\":\"2021-03-03T12:33:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/\"},\"wordCount\":263,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/\",\"name\":\"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg=\",\"datePublished\":\"2021-03-03T12:33:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/","og_locale":"en_US","og_type":"article","og_title":"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference - Market Newsdesk","og_description":"WEST CHESTER, Pa., March 03, 2021 (GLOBE NEWSWIRE) &#8212; Verrica Pharmaceuticals Inc. (\u201cVerrica\u201d) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will present a business overview at the H.C. Wainwright Annual Global Life Sciences Conference, taking place March 9-10, 2021. A pre-recorded presentation will be available for on-demand access beginning at 7:00 a.m. ET on Tuesday, March 9, 2021. Participants may access a webcast of the event through the following link:https:\/\/journey.ct.events\/view\/920684dd-5942-496a-9960-f3619118a62d. The webcast can also be accessed in the Investors\/Presentations &amp; Events section of the Verrica website at www.verrica.com. The webcast replay will be available shortly after conclusion of the event for 30 days. About &hellip; Continue reading \"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-03T12:33:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference","datePublished":"2021-03-03T12:33:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/"},"wordCount":263,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/","name":"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg=","datePublished":"2021-03-03T12:33:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA2OSM0MDQ0ODYwIzIxMjA3NDg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verrica-pharmaceuticals-announces-participation-in-the-h-c-wainwright-annual-global-life-sciences-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/449339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=449339"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/449339\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=449339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=449339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=449339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}